Genalyte Revenue and Competitors

Location

$141.8M

Total Funding

Estimated Revenue & Valuation

  • Genalyte's estimated annual revenue is currently $12.3M per year.(i)
  • Genalyte received $36.0M in venture funding in November 2016.
  • Genalyte's estimated revenue per employee is $140,000
  • Genalyte's total funding is $141.8M.

Employee Data

  • Genalyte has 88 Employees.(i)
  • Genalyte grew their employee count by -15% last year.

Genalyte's People

NameTitleEmail/Phone
1
FounderReveal Email/Phone
2
CEOReveal Email/Phone
3
CMOReveal Email/Phone
4
SVP Product and OperationsReveal Email/Phone
5
VP, Product MarketingReveal Email/Phone
6
General Counsel and Corporate SecretaryReveal Email/Phone
7
Sr. Director EngineeringReveal Email/Phone
8
Associate Director, IVD ManufacturingReveal Email/Phone
9
DirectorReveal Email/Phone
10
Chief Financial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.5M1328%$1.4BN/A
Add Company

What Is Genalyte?

In an age when information can be transmitted at the speed of light, physicians and patients should be able to expect reliable bloodwork results within minutes of a test being completed. Leaving a patient in limbo waiting days for results while test samples are shipped across the country is an unacceptable standard in the 21st century. Rapid test results that allow physicians to confidently make data-driven treatment decisions during a patient's office visit should become the new standard of care. Genalyte's vision is to transform the doctor-patient relationship by bringing the doctor, the patient, and the lab together to provide results when they matter: Now. Genalyte's platform is being designed with the goal of providing test results from a whole blood sample within fifteen minutes in the physician's office. Providing diagnostic results at the time and place they are needed when the patient is sitting in front of the doctor has the potential to empower physicians, improve quality of care for patients, and reduce resource utilization across the healthcare system. Genalyte's technology is based on a proprietary silicon biosensor design that is currently in use by pharmaceutical companies, contract research organizations and academic researchers. For more information, visit www.genalyte.com.

keywords:Biotechnology,Healthcare,Healthcare Providers,Medical Diagnostics,Pharmaceuticals

$141.8M

Total Funding

88

Number of Employees

$12.3M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Genalyte News

2021-01-12 - Genalyte Finds $50M Funding

San Diego-based Genalyte, a developer of laboratory diagnostics and analytics products, announced on Monday that it has raised $50M in a funding round. The funding was led by Verily, an Alphabet company, and also included Provenio Capital, Redmile, Khosla Ventures, HBM Partners, Samsara and othe ...

2021-01-11 - Genalyte Announces Oversubscribed $50 Million Financing Round to Expand Testing Menu and Deploy Platform

SAN DIEGO, Jan. 11, 2021 /PRNewswire/ -- Genalyte, a leading diagnostics and analytics company, announced today the closure of $50 million in financing. Genalyte's Maverick™ Diagnostic System (MDS) uses silicon chip based photonic ring resonance technology to perform multiple, simultaneous, ra ...

2020-10-15 - Genalyte Obtains FDA Emergency Use Authorization for Rapid COVID-19 Antibody Test

SAN DIEGO, Oct. 15, 2020 /PRNewswire/ -- Genalyte, a leading point-of-care diagnostics and analytics company, announced today its SARS-CoV-2 Multi-Antigen Serology Panel has received Emergency Use Authorization (EUA) from the FDA. The panel tests for the detection of IgG and IgM antibodies the ...

2017-10-20 - BaseHealth Lands $8.5M for Predictive Analytics Platform to Uncover ‘Invisible Patients’

BaseHealth, a predictive, evidence-based, and data-driven population health management solution that targets the unknown risk by identifying the “Invisible Patients” has raised $8.5 million in Series C funding led by HBM Healthcare Investments. The Sunnyvale, CA-based digital health startup plan ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M8811%N/A
#2
$12.8M8811%N/A
#3
$22.1M8829%N/A
#4
$13.6M887%$14.3M
#5
$12.9M880%$194.5M

Genalyte Funding

DateAmountRoundLead InvestorsReference
2015-08-19$44.0MCKhosla VenturesArticle
2016-11-22$36.0MUndisclosedKhosla VenturesArticle